about
An overview of radiotracers in nuclear cardiology.Quantification of SPECT myocardial perfusion imaging.Post-stress left ventricular ejection fraction drop in patients with diabetes: a gated myocardial perfusion imaging study.Prevalence and Severity of Myocardial Perfusion Imaging Abnormalities in Inmate Subjects.EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revisionComparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction.Myocardial perfusion imaging after coronary revascularization: a clinical appraisal.Prognostic value of normal stress myocardial perfusion imaging in diabetic patients: a meta-analysis.Transient ischemic dilation in patients with diabetes mellitus: prognostic value and effect on clinical outcome after coronary revascularization.Diagnostic accuracy of low-dose dobutamine echocardiography in predicting post-revascularisation recovery of function in patients with chronic coronary artery disease: relationship to thallium-201 uptake.Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial.Beyond ultrasound: advances in multimodality cardiac imaging.Comparison of prognostic value of negative dobutamine stress echocardiography versus single-photon emission computed tomography after acute myocardial infarction.Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction.Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care.Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity.Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography.Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease.Cardiovascular risk stratification in diabetic patients: is all in METS?Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis.Usefulness of stress cardiac single-photon emission computed tomographic imaging late after percutaneous coronary intervention for assessing cardiac events and time to such events.Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram.EANM/ESC guidelines for radionuclide imaging of cardiac functionDoes a Gender-Related Effect of Growth Hormone (GH) Replacement Exist on Cardiovascular Risk Factors, Cardiac Morphology, and Performance and Atherosclerosis? Results of a Two-Year Open, Prospective Study in Young Adult Men and Women with Severe GH DC-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imagingThe role of radiolabeled somatostatin analogs in adrenal imagingLeft ventricular diastolic function and cardiac performance during exercise in patients with acromegalyMyocardial viability assessment in regions of left ventricular dysfunction. Part I: Radionuclide imaging and clinical implicationsTc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluationDirect comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery diseaseCombined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunctionRadioimmunoguided surgery in colorectal cancer: a 6-year experience with four different technical solutionsExercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjectionPrognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patientsQuantitative myocardial-perfusion SPECT: comparison of three state-of-the-art software packagesStress cardiac single-photon emission computed tomographic imaging late after coronary artery bypass surgery for risk stratification and estimation of time to cardiac eventsSingle-photon emission computed tomography after nitrate administration predicts cardiac events in patients with previous myocardial infarction and left ventricular dysfunctionSurvival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardiumCardiac performance during exercise in patients with Fabry's diseaseCardiac performance during exercise in hypertensive patients without ventricular hypertrophy
P50
Q34122275-A4864FCA-01F0-4E98-90C8-994643CCDBA9Q34658330-99E5A3E3-BCCC-4D1C-87FC-1339809BE227Q35041822-DB22D88A-F287-4574-A0E7-E1BA938AAE8FQ35705534-C0A94BFF-F32F-4DDA-BF8D-EDAD7E4E6075Q36109226-24BD20C3-401F-4D67-AFBA-9058C6323E1AQ36688639-CB775370-B7F5-4064-B22C-95EBAAB70A5AQ38100656-A7954E02-86B2-49E5-BAA3-8A2FE1DD539EQ38219935-8DF72218-4AD1-43E8-BA63-11ECA0B8F5B4Q43416647-754B85A5-48AE-45ED-8952-A3BC9508A8C0Q43794920-28B25F50-F9F3-4CE1-90EE-AC8ED3B5BDABQ44667016-06FEFDBB-4F14-45F4-889F-127109242D4BQ46195604-2E3FAC80-3921-414B-8D30-EB7C4EFD8988Q46567570-7668BC85-87F7-4AA7-8566-999A472ECF32Q47390670-266EC234-CEB8-49A9-A77F-669B539B9110Q48560575-852280DF-A993-4EDC-BB16-C73810284EACQ50999403-FA1069B1-4737-44B4-B512-D2344B8FF774Q51164629-DCC42810-2046-4A45-BAD3-2B4873723645Q51357838-A5D6E4CC-D374-42B2-ABEE-E98056A2EB81Q53055242-CA240751-B833-4FB1-A4E2-C9E6134A53DCQ53093385-26C4E8A8-6010-45A6-8DD0-35A5943D03D2Q53471077-DECA096F-7B19-4356-8D89-A49AD7CB6AFEQ54325469-7BE87672-8F9B-4205-8117-4D7149B37261Q57682319-7B4EAF5F-B150-4DAB-9A16-6C17AE16FD35Q60690874-C78C8E27-6579-419B-A3A3-968043CCD4AAQ61055224-C93E73D9-78C3-41F9-A8CA-7F4BD4E2615FQ71827073-DDCF364B-5F6B-4812-80E0-46DABFD0C913Q73933470-ACCC7300-B37F-4A03-A456-EB62CE178F2FQ74012513-4586D657-C831-483A-9F59-D7B770A93EE5Q74575705-0C4A3CAC-0F1B-4A0F-903E-C662D52CAAB9Q74788371-EE2594A6-1E9A-466E-B23E-10766EFE4376Q77142995-B78D1449-3F4E-462C-8046-A25A08D9B90EQ77602328-D33A6123-4919-477E-94BA-7146015F0F00Q77932229-FFE1E1BE-C6D0-4268-A582-0043383FE7F6Q78879774-E0721A24-4726-4EF0-8C80-E30F3FB90B00Q80613482-2BF7389C-E39D-4952-8DDE-3B93BE894F1DQ81584554-26D51482-B6B6-477E-96E7-339F63616F63Q81586738-F964BC2E-121C-4FBD-AE29-6EED1395C40AQ81635233-1778A7B7-7282-4330-A6F5-24C844B45C9FQ82672639-A3254864-3146-4A1D-A48C-15B83B8C16FCQ83977409-DD3F4BBE-CBA5-432B-91E6-D1990FC1E118
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wanda Acampa
@ast
Wanda Acampa
@en
Wanda Acampa
@es
Wanda Acampa
@nl
type
label
Wanda Acampa
@ast
Wanda Acampa
@en
Wanda Acampa
@es
Wanda Acampa
@nl
prefLabel
Wanda Acampa
@ast
Wanda Acampa
@en
Wanda Acampa
@es
Wanda Acampa
@nl
P106
P1153
6603928944
P31
P496
0000-0003-2187-4076